Tirzepatide typically produces noticeable weight loss within 4-8 weeks, with maximum effects occurring over 6-12 months
marketed as Mounjaro for T2DM and Zepbound for obesity), is a 39-amino acid peptide acylated with a C20:0 fatty diacid moiety to lysine residue at position 20 with a molecular weight of 4.8 kDa [ Figure 2 , Table 1 ]
129,136,137,138,139,140 However, clinical translation of saRNAs remains challenging due to the absence of an immune system in xenograft models and the complexity of drug action in the human body
While reducing body mass index (BMI) does reduce the risk of cancer incidence, it is not to the extent that lowering BMI reduces mortality risk
And emerging technologies like GLP-1 patches may eventually make this entire discussion obsolete
Unlike some medications that require careful tapering, GLP-1 drugs such as semaglutide, dulaglutide, and liraglutide do not typically cause physical dependence or withdrawal symptoms